These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1393 related articles for article (PubMed ID: 33707476)

  • 21. Efficacy of Peracetic Acid and Sodium Hypochlorite against SARS-CoV-2 on Contaminated Surfaces.
    Morris JN; Esseili MA
    Appl Environ Microbiol; 2023 Jul; 89(7):e0062223. PubMed ID: 37347194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges.
    Mohan SV; Hemalatha M; Kopperi H; Ranjith I; Kumar AK
    Chem Eng J; 2021 Feb; 405():126893. PubMed ID: 32901196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses.
    Rosas-Murrieta NH; Rodríguez-Enríquez A; Herrera-Camacho I; Millán-Pérez-Peña L; Santos-López G; Rivera-Benítez JF
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination.
    Otter JA; Donskey C; Yezli S; Douthwaite S; Goldenberg SD; Weber DJ
    J Hosp Infect; 2016 Mar; 92(3):235-50. PubMed ID: 26597631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amuchina Gel Xgerm hand rub
    de Joannon AC; Testa A; Falsetto N; Procaccini M; Ragni L
    Future Microbiol; 2021 Jul; 16(11):797-800. PubMed ID: 34165328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of an Eco-Sustainable Probiotic-Cleaning Formulation in Reducing Infectivity of Enveloped Viruses.
    D'Accolti M; Soffritti I; Bonfante F; Ricciardi W; Mazzacane S; Caselli E
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
    Joseph J; Karthika T; Das VRA; Raj VS
    Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.
    Siddharta A; Pfaender S; Vielle NJ; Dijkman R; Friesland M; Becker B; Yang J; Engelmann M; Todt D; Windisch MP; Brill FH; Steinmann J; Steinmann J; Becker S; Alves MP; Pietschmann T; Eickmann M; Thiel V; Steinmann E
    J Infect Dis; 2017 Mar; 215(6):902-906. PubMed ID: 28453839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review.
    Chiappa F; Frascella B; Vigezzi GP; Moro M; Diamanti L; Gentile L; Lago P; Clementi N; Signorelli C; Mancini N; Odone A
    J Hosp Infect; 2021 Aug; 114():63-78. PubMed ID: 34029626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
    Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
    [No Abstract]   [Full Text] [Related]  

  • 35. Residual antimicrobial coating efficacy against SARS-CoV-2.
    Hardison RL; Ryan SP; Limmer RA; Crouse M; Nelson SW; Barriga D; Ghere JM; Stewart MJ; Lee SD; Taylor BM; James RR; Calfee MW; Howard MW
    J Appl Microbiol; 2022 Apr; 132(4):3375-3386. PubMed ID: 34981882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incomplete IgG avidity maturation after seasonal coronavirus infections.
    Struck F; Schreiner P; Staschik E; Wochinz-Richter K; Schulz S; Soutschek E; Motz M; Bauer G
    J Med Virol; 2022 Jan; 94(1):186-196. PubMed ID: 34427932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.
    Al-Sharif E; Strianese D; AlMadhi NH; D'Aponte A; dell'Omo R; Di Benedetto R; Costagliola C
    Int Ophthalmol; 2021 Jan; 41(1):349-362. PubMed ID: 32880786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19.
    Sharma HN; Latimore COD; Matthews QL
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.